ADC Therapeutics SA (ADCT) Gross margin 2022–2025
ADC Therapeutics SA (ADCT) gross margin by fiscal year — reported gross profit divided by reported revenue.
92.9%FY2025 · since FY2022: 95.6% → 92.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 92.9% | +1.3 pp |
| FY2024 | 91.6% | -4.7 pp |
| FY2023 | 96.3% | +0.7 pp |
| FY2022 | 95.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Operating incomeADCT Operating marginADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →